跳至主要内容
临床试验/NCT03715907
NCT03715907已完成不适用

Financial Incentives for Care Gaps: A Randomized Controlled Trial

Massachusetts Institute of Technology1 个研究点 分布在 1 个国家目标入组 8,042 人开始时间: 2018年8月31日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
8,042
试验地点
1
主要终点
Proportion of care gaps closed

研究概览

简要总结

This project seeks to understand how individuals respond to financial incentive programs for wellness care. In a randomized controlled trial among customers with care gaps, the investigators will experimentally compare the impacts of incentives for gap closure (gift cards), information on existing gaps (mailers), and no intervention. The research objectives are to assess how responsive individuals are to incentives for, and to information about, existing care gaps; and to assess spillovers from incentives onto other care. In addition, impacts on downstream utilization will be studied, which may be impacted if financial incentives are effective at increasing wellness visits.

详细描述

Setting and sample:

The study will be conducted among individuals enrolled in an insurance plan offered by an insurance company in the state of Nebraska.

The sample will include a subset of individuals eligible for a program designed to improve delivery of care by incentivizing individuals and their dependents to fill "care gaps" - gaps in recommended care.

Interventions:

The design will entail two overarching interventions for each incentivized care gap: Incentives, and Information Only. In addition, there will be a control that receives neither.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Is a partner organization member in the region of study
  • •Has a care gap in one of the six target areas

排除标准

  • •Participating in another select high-intensity wellness intervention provided by the partner organization

研究组 & 干预措施

Control: W34

No Intervention

Members receiving the Control intervention for the W34 (3- to 6-year-old well visit) gap will not receive a mailer.

Information only: W34

Experimental

Members receiving the Information Only intervention for the W34 care gap will receive a mailer informing them of that gap, but not of financial incentives for closing the care gap.

干预措施: Information (Behavioral)

Incentives: W34

Experimental

Informational W34 mailer and incentive to close gap

干预措施: Financial Incentives (Behavioral)

Incentives: W34

Experimental

Informational W34 mailer and incentive to close gap

干预措施: Information (Behavioral)

Control: LSC

No Intervention

Members receiving the Control intervention for the LSC (lead screening in children) gap will not receive a mailer.

Information only: LSC

Experimental

Informational LSC mailer and incentive to close gap

干预措施: Information (Behavioral)

Incentives: LSC

Experimental

Members receiving the Incentives intervention for the LSC care gap will receive a mailer informing them of the gap and eligibility for a gift card if they close the gap.

干预措施: Financial Incentives (Behavioral)

Incentives: LSC

Experimental

Members receiving the Incentives intervention for the LSC care gap will receive a mailer informing them of the gap and eligibility for a gift card if they close the gap.

干预措施: Information (Behavioral)

Control: IMA

No Intervention

No mailer for IMA (immunizations) gap

Information only: IMA

Experimental

Informational IMA mailer

干预措施: Information (Behavioral)

Incentives: IMA

Experimental

Informational IMA mailer and incentive

干预措施: Financial Incentives (Behavioral)

Incentives: IMA

Experimental

Informational IMA mailer and incentive

干预措施: Information (Behavioral)

Control: CDC

No Intervention

No mailer for CDC (clinical diabetes care) gap

Information only: CDC

Experimental

Informational CDC mailer

干预措施: Information (Behavioral)

Incentives: CDC

Experimental

Informational CDC mailer and incentive

干预措施: Financial Incentives (Behavioral)

Incentives: CDC

Experimental

Informational CDC mailer and incentive

干预措施: Information (Behavioral)

Control: CCS

No Intervention

No mailer for CCS (cervical cancer screening)

Information only: CCS

Experimental

Informational CCS mailer

干预措施: Information (Behavioral)

Incentives: CCS

Experimental

Informational CCS mailer and incentive

干预措施: Financial Incentives (Behavioral)

Incentives: CCS

Experimental

Informational CCS mailer and incentive

干预措施: Information (Behavioral)

Control: AWC

No Intervention

No mailer for AWC (adolescent well-care visit) gap

Information only: AWC

Experimental

Informational AWC mailer

干预措施: Information (Behavioral)

Incentives: AWC

Experimental

Informational AWC mailer and incentive

干预措施: Financial Incentives (Behavioral)

Incentives: AWC

Experimental

Informational AWC mailer and incentive

干预措施: Information (Behavioral)

结局指标

主要结局

Proportion of care gaps closed

时间窗: 18 months, from the date of randomization until December 31, 2019

Care gap closure for all care gaps. A care gap is considered closed for an individual or dependent who had not received recommended care (i.e. who had a care gap) at the time of enrollment at the time they receive the recommended care. For example, if a dependent child has not received lead screening (LSC) at the time of enrollment, the LSC care gap is considered closed once the child receives a lead screening.

Proportion of care gaps closed

时间窗: 6 months, from the date of randomization until end-of-year (i.e., December 31, 2018)

Care gap closure for all care gaps. A care gap is considered closed for an individual or dependent who had not received recommended care (i.e. who had a care gap) at the time of enrollment at the time they receive the recommended care. For example, if a dependent child has not received lead screening (LSC) at the time of enrollment, the LSC care gap is considered closed once the child receives a lead screening.

次要结局

  • Health care expenditure during study - Total claims(6 months, from the date of randomization until end-of-year)
  • Health care expenditure following study - Total claims(12 months, from December 31 2018 - December 31 2019)
  • Outpatient visits during study(6 months, from the date of randomization until end-of-year)
  • Prescriptions during study(6 months, from the date of randomization until end-of-year)
  • Outpatient visits following study(12 months, from December 31 2018 - December 31 2019)
  • Inpatient visits during study(6 months, from the date of randomization until end-of-year)
  • Inpatient visits following study(12 months, from December 31 2018 - December 31 2019)
  • Prescriptions following study(12 months, from December 31 2018 - December 31 2019)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验